Sign in to view content

Brolucizumab for Neovascular AMD: The 2 Year HAWK and HARRIER Results

Pravin U. Dugel, MD

Video
Published 2018

Related

The Changing Avastin Landscape
Paul Hahn, MD, PhD, FASRS
Annual Meeting Talks
2019
A Comparison of the Anatomical Efficacy of Brolucizumab Versus Aflibercept in nAMD Patients: Matched 16-Week Results From the HAWK and HARRIER Studies
Pravin U. Dugel, MD
Annual Meeting Talks
2018
Factors Associated with Worsening Proliferative Diabetic Retinopathy
Carl W. Baker, MD, FASRS
Updates from the Field
2017

Category: AMD-Neovascular

See more